Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Recruiting now · Phase 1/Phase 2
Conditions studied: Relapse/Refractory B-cell Acute Lymphoblastic Leukemia
In brief
The goal of this clinical trial is to evaluate the safety and efficacy of CD19 CAR-T cells in pediatric patients of all genders, aged 2 to 18 years, with relapsing or refractory B cell acute lymphoblastic leukemia (r/r B-ALL). The main questions it aims to answer are as following: 1. What is the percentage of patients with overall remission rate (ORR) of complete response (CR) or complete remission with incomplete blood count recovery (CRi)? 2. What is the rate of Event-free survival at first month and 2-3 months after intervention? 3. What is the rate of Overall survival at first month and at 3 months after the intervention?
Key facts
- Study ID
- NCT06635330
- Run by
- Kara Yakhteh Tajhiz Azma Company
- People needed
- 5
- Starts
- 2024-05-20
- Expected to finish
- 2027-09-22
- Last updated by the study team
- 2024-10-10
Who can join
Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ages 2 to 18 years with relapsed or refractory CD19+ B-ALL
- Presence of disease in the bone marrow
- Able to tolerate the apheresis process
- Life expectancy \> 12 weeks
- Lansky or Karnofsky score \> 50%
- At least 7 days passed since the last chemotherapy and the last treatment with corticosteroids
- Informed consent
- Having potential donor for stem cell transplantation
You may not qualify if…
- Presence of active malignancy other than the disease under study
- Chloroma and leukemic infiltration on MRI or significant neurological symptoms
- Any CNS disorder
- Presence of active GVHD
- Radiation therapy within last 14 days
- History of Anti-CD19 or Anti-CD20 therapy
- Donor lymphocyte injection or other cell therapy methods within the last 30 days
- Presence of severe active infection
- Organ dysfunction
Where it is running
- Pediatric cell and gene therapy research center, Children medical center — Tehran, Tehran Province, Iran (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.